Concepts (217)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Breast Neoplasms | 16 | 2026 | 482 | 4.150 |
Why?
|
| Obesity | 13 | 2025 | 699 | 2.420 |
Why?
|
| Mammary Neoplasms, Experimental | 6 | 2021 | 48 | 2.190 |
Why?
|
| Receptors, Estrogen | 3 | 2023 | 43 | 1.530 |
Why?
|
| Mammary Glands, Animal | 7 | 2020 | 41 | 1.440 |
Why?
|
| Weight Gain | 5 | 2023 | 76 | 1.230 |
Why?
|
| Tamoxifen | 4 | 2021 | 34 | 1.200 |
Why?
|
| Adipose Tissue | 4 | 2021 | 195 | 1.030 |
Why?
|
| Animals | 30 | 2026 | 10684 | 0.930 |
Why?
|
| Mice | 19 | 2026 | 4802 | 0.850 |
Why?
|
| Diabetes Mellitus, Type 2 | 2 | 2025 | 344 | 0.850 |
Why?
|
| Fibroblast Growth Factor 1 | 1 | 2023 | 10 | 0.820 |
Why?
|
| Estrogens | 2 | 2023 | 56 | 0.760 |
Why?
|
| Tumor Microenvironment | 3 | 2021 | 194 | 0.760 |
Why?
|
| Antineoplastic Agents, Hormonal | 2 | 2021 | 29 | 0.760 |
Why?
|
| Adipocytes | 2 | 2021 | 59 | 0.730 |
Why?
|
| Female | 27 | 2026 | 15624 | 0.710 |
Why?
|
| Metformin | 3 | 2018 | 36 | 0.700 |
Why?
|
| Breast | 2 | 2020 | 52 | 0.690 |
Why?
|
| Neoplasms | 4 | 2025 | 874 | 0.680 |
Why?
|
| Fatty Acid Synthase, Type I | 3 | 2014 | 8 | 0.640 |
Why?
|
| Cell Transformation, Neoplastic | 3 | 2016 | 120 | 0.610 |
Why?
|
| Triple Negative Breast Neoplasms | 2 | 2022 | 36 | 0.600 |
Why?
|
| Receptor, Fibroblast Growth Factor, Type 1 | 1 | 2018 | 10 | 0.580 |
Why?
|
| Lactation | 4 | 2019 | 76 | 0.570 |
Why?
|
| Gene Expression Regulation, Neoplastic | 5 | 2022 | 472 | 0.560 |
Why?
|
| Receptors, Androgen | 1 | 2017 | 26 | 0.530 |
Why?
|
| Rats | 10 | 2022 | 1588 | 0.530 |
Why?
|
| Basic Helix-Loop-Helix Transcription Factors | 4 | 2011 | 53 | 0.530 |
Why?
|
| Ovary | 1 | 2017 | 72 | 0.520 |
Why?
|
| Glucose Transporter Type 1 | 1 | 2016 | 16 | 0.520 |
Why?
|
| Humans | 26 | 2026 | 28851 | 0.510 |
Why?
|
| Receptor, ErbB-2 | 1 | 2016 | 33 | 0.510 |
Why?
|
| Mice, Transgenic | 5 | 2021 | 513 | 0.510 |
Why?
|
| Cell Line, Tumor | 9 | 2026 | 1350 | 0.480 |
Why?
|
| Nuclear Proteins | 2 | 2014 | 249 | 0.480 |
Why?
|
| Transcription Factors | 3 | 2014 | 523 | 0.480 |
Why?
|
| MicroRNAs | 2 | 2022 | 302 | 0.470 |
Why?
|
| Fatty Acids | 2 | 2014 | 218 | 0.410 |
Why?
|
| Neoplastic Stem Cells | 1 | 2014 | 141 | 0.400 |
Why?
|
| Disease Progression | 4 | 2018 | 477 | 0.390 |
Why?
|
| Ovariectomy | 4 | 2022 | 53 | 0.380 |
Why?
|
| Postmenopause | 4 | 2022 | 84 | 0.370 |
Why?
|
| Rodentia | 2 | 2022 | 14 | 0.370 |
Why?
|
| Disease Models, Animal | 5 | 2026 | 1507 | 0.320 |
Why?
|
| Cell Differentiation | 1 | 2010 | 427 | 0.260 |
Why?
|
| Cell Proliferation | 4 | 2019 | 824 | 0.240 |
Why?
|
| Tetraspanin 30 | 1 | 2026 | 7 | 0.240 |
Why?
|
| Glucagon-Like Peptide-1 Receptor | 1 | 2025 | 2 | 0.240 |
Why?
|
| Luciferases | 1 | 2026 | 54 | 0.240 |
Why?
|
| Carcinoma, Intraductal, Noninfiltrating | 1 | 2026 | 14 | 0.240 |
Why?
|
| Energy Metabolism | 2 | 2020 | 215 | 0.230 |
Why?
|
| Xenograft Model Antitumor Assays | 3 | 2020 | 275 | 0.230 |
Why?
|
| Extracellular Vesicles | 1 | 2026 | 53 | 0.230 |
Why?
|
| Proteomics | 2 | 2023 | 197 | 0.220 |
Why?
|
| Ligands | 1 | 2023 | 178 | 0.200 |
Why?
|
| Mammary Tumor Virus, Mouse | 2 | 2014 | 4 | 0.190 |
Why?
|
| Precursor Cell Lymphoblastic Leukemia-Lymphoma | 1 | 2023 | 43 | 0.190 |
Why?
|
| Estradiol | 1 | 2023 | 176 | 0.190 |
Why?
|
| Mice, Inbred C57BL | 3 | 2021 | 1653 | 0.190 |
Why?
|
| Tumor Burden | 1 | 2022 | 110 | 0.180 |
Why?
|
| Signal Transduction | 4 | 2018 | 1469 | 0.180 |
Why?
|
| Aromatase Inhibitors | 1 | 2021 | 2 | 0.180 |
Why?
|
| Mice, Obese | 1 | 2021 | 22 | 0.180 |
Why?
|
| Selective Estrogen Receptor Modulators | 1 | 2021 | 8 | 0.180 |
Why?
|
| Thinness | 1 | 2021 | 21 | 0.180 |
Why?
|
| Transgenes | 1 | 2021 | 63 | 0.180 |
Why?
|
| Antineoplastic Agents | 2 | 2017 | 686 | 0.180 |
Why?
|
| Hyperinsulinism | 1 | 2021 | 17 | 0.170 |
Why?
|
| Up-Regulation | 2 | 2020 | 247 | 0.170 |
Why?
|
| Dietary Sugars | 1 | 2020 | 1 | 0.170 |
Why?
|
| Hormone Replacement Therapy | 1 | 2020 | 9 | 0.170 |
Why?
|
| Menopause | 1 | 2020 | 30 | 0.170 |
Why?
|
| Carcinogens | 1 | 2020 | 39 | 0.170 |
Why?
|
| Kaplan-Meier Estimate | 2 | 2020 | 194 | 0.160 |
Why?
|
| Appetite | 1 | 2020 | 19 | 0.160 |
Why?
|
| Thyroid Hormones | 1 | 2020 | 37 | 0.160 |
Why?
|
| Carcinogenesis | 1 | 2020 | 81 | 0.160 |
Why?
|
| Diet | 2 | 2021 | 241 | 0.160 |
Why?
|
| Eating | 1 | 2020 | 71 | 0.160 |
Why?
|
| Wnt4 Protein | 1 | 2019 | 1 | 0.160 |
Why?
|
| Physical Conditioning, Animal | 1 | 2020 | 46 | 0.160 |
Why?
|
| Adiposity | 1 | 2020 | 94 | 0.160 |
Why?
|
| Mammography | 1 | 2021 | 82 | 0.160 |
Why?
|
| Wnt3A Protein | 1 | 2019 | 6 | 0.160 |
Why?
|
| Acyltransferases | 1 | 2019 | 24 | 0.160 |
Why?
|
| Diet, High-Fat | 1 | 2020 | 144 | 0.160 |
Why?
|
| Insulin Resistance | 1 | 2021 | 176 | 0.150 |
Why?
|
| Body Weight | 1 | 2020 | 250 | 0.150 |
Why?
|
| Liver X Receptors | 1 | 2019 | 22 | 0.150 |
Why?
|
| Wnt Signaling Pathway | 1 | 2019 | 67 | 0.150 |
Why?
|
| Epithelium | 1 | 2019 | 40 | 0.150 |
Why?
|
| Milk | 1 | 2019 | 29 | 0.150 |
Why?
|
| Transcriptome | 1 | 2020 | 231 | 0.150 |
Why?
|
| Loss of Function Mutation | 1 | 2018 | 4 | 0.150 |
Why?
|
| Diabetes Mellitus | 1 | 2021 | 215 | 0.140 |
Why?
|
| Aromatase | 1 | 2018 | 12 | 0.140 |
Why?
|
| Mammary Neoplasms, Animal | 1 | 2018 | 21 | 0.140 |
Why?
|
| Homeodomain Proteins | 1 | 2018 | 79 | 0.140 |
Why?
|
| Adenocarcinoma | 2 | 2012 | 300 | 0.140 |
Why?
|
| Protein Kinase C-delta | 1 | 2017 | 6 | 0.130 |
Why?
|
| Cholesterol | 1 | 2019 | 203 | 0.130 |
Why?
|
| Phenylthiohydantoin | 1 | 2017 | 8 | 0.130 |
Why?
|
| Nitriles | 1 | 2017 | 38 | 0.130 |
Why?
|
| Radiation-Protective Agents | 1 | 2017 | 22 | 0.130 |
Why?
|
| Benzamides | 1 | 2017 | 39 | 0.130 |
Why?
|
| Organic Cation Transport Proteins | 1 | 2017 | 6 | 0.130 |
Why?
|
| Chromatography, Liquid | 1 | 2017 | 79 | 0.130 |
Why?
|
| Testosterone | 1 | 2017 | 74 | 0.130 |
Why?
|
| Gene Knockout Techniques | 1 | 2016 | 36 | 0.130 |
Why?
|
| Steroids | 1 | 2017 | 58 | 0.130 |
Why?
|
| Epithelial Cells | 2 | 2010 | 265 | 0.130 |
Why?
|
| Salivary Glands | 1 | 2017 | 58 | 0.130 |
Why?
|
| Immunohistochemistry | 1 | 2017 | 465 | 0.120 |
Why?
|
| Mass Spectrometry | 1 | 2017 | 196 | 0.120 |
Why?
|
| Interleukin-6 | 1 | 2017 | 198 | 0.120 |
Why?
|
| Membrane Proteins | 1 | 2019 | 485 | 0.120 |
Why?
|
| Protein Kinase Inhibitors | 1 | 2017 | 165 | 0.120 |
Why?
|
| Protein Isoforms | 3 | 2011 | 119 | 0.120 |
Why?
|
| Glucose | 1 | 2016 | 209 | 0.110 |
Why?
|
| Fatty Acid Synthases | 1 | 2014 | 7 | 0.110 |
Why?
|
| Tumor Cells, Cultured | 1 | 2014 | 314 | 0.110 |
Why?
|
| Neoplasm Metastasis | 1 | 2014 | 164 | 0.110 |
Why?
|
| Biomarkers | 1 | 2017 | 776 | 0.100 |
Why?
|
| Overnutrition | 1 | 2012 | 1 | 0.100 |
Why?
|
| Receptors, Progesterone | 1 | 2012 | 17 | 0.100 |
Why?
|
| Tissue Extracts | 1 | 2012 | 7 | 0.090 |
Why?
|
| Gas Chromatography-Mass Spectrometry | 1 | 2012 | 29 | 0.090 |
Why?
|
| Complex Mixtures | 1 | 2012 | 12 | 0.090 |
Why?
|
| Isotope Labeling | 1 | 2012 | 31 | 0.090 |
Why?
|
| STAT3 Transcription Factor | 1 | 2011 | 97 | 0.080 |
Why?
|
| Fatty Acid-Binding Proteins | 1 | 2010 | 6 | 0.080 |
Why?
|
| Cells, Cultured | 2 | 2010 | 1022 | 0.080 |
Why?
|
| NF-kappa B | 1 | 2011 | 191 | 0.080 |
Why?
|
| Fatty Acids, Unsaturated | 1 | 2010 | 68 | 0.080 |
Why?
|
| Mammary Glands, Human | 1 | 2009 | 19 | 0.080 |
Why?
|
| Fluorescent Dyes | 1 | 2010 | 93 | 0.080 |
Why?
|
| Genes, ras | 1 | 2009 | 12 | 0.080 |
Why?
|
| Gene Expression Regulation, Developmental | 1 | 2010 | 129 | 0.070 |
Why?
|
| Cell Culture Techniques | 1 | 2009 | 117 | 0.070 |
Why?
|
| Kinetics | 2 | 2026 | 553 | 0.070 |
Why?
|
| CCAAT-Enhancer-Binding Protein-beta | 1 | 2009 | 26 | 0.070 |
Why?
|
| Receptors, Notch | 1 | 2009 | 44 | 0.070 |
Why?
|
| Cell Transdifferentiation | 1 | 2007 | 2 | 0.070 |
Why?
|
| Mesoderm | 1 | 2007 | 16 | 0.070 |
Why?
|
| Matrix Metalloproteinase 2 | 1 | 2007 | 40 | 0.070 |
Why?
|
| Liver | 2 | 2010 | 471 | 0.060 |
Why?
|
| Lipogenesis | 2 | 2019 | 29 | 0.060 |
Why?
|
| Male | 3 | 2020 | 13921 | 0.060 |
Why?
|
| Fatty Liver, Alcoholic | 1 | 2005 | 1 | 0.060 |
Why?
|
| Sialoglycoproteins | 1 | 2005 | 8 | 0.060 |
Why?
|
| Neutrophil Infiltration | 1 | 2005 | 19 | 0.060 |
Why?
|
| Rats, Wistar | 2 | 2017 | 153 | 0.060 |
Why?
|
| RNA, Small Interfering | 2 | 2019 | 198 | 0.050 |
Why?
|
| Apoptosis | 3 | 2017 | 780 | 0.050 |
Why?
|
| Mice, Knockout | 2 | 2020 | 874 | 0.050 |
Why?
|
| RNA, Messenger | 2 | 2019 | 668 | 0.040 |
Why?
|
| Gene Expression Regulation | 2 | 2019 | 634 | 0.040 |
Why?
|
| Nutritional Status | 1 | 2021 | 80 | 0.040 |
Why?
|
| MCF-7 Cells | 1 | 2020 | 34 | 0.040 |
Why?
|
| Mice, SCID | 1 | 2020 | 60 | 0.040 |
Why?
|
| Mice, Inbred NOD | 1 | 2020 | 50 | 0.040 |
Why?
|
| Disease-Free Survival | 1 | 2020 | 236 | 0.040 |
Why?
|
| Energy Intake | 1 | 2020 | 69 | 0.040 |
Why?
|
| Recombinant Proteins | 2 | 2012 | 416 | 0.040 |
Why?
|
| Culture Media, Conditioned | 1 | 2019 | 31 | 0.040 |
Why?
|
| Paracrine Communication | 1 | 2019 | 17 | 0.040 |
Why?
|
| Coculture Techniques | 1 | 2019 | 55 | 0.040 |
Why?
|
| African Americans | 1 | 2022 | 352 | 0.040 |
Why?
|
| RNA Interference | 1 | 2019 | 137 | 0.040 |
Why?
|
| Benzylamines | 1 | 2019 | 19 | 0.040 |
Why?
|
| Protein Transport | 1 | 2019 | 158 | 0.040 |
Why?
|
| Sterol Regulatory Element Binding Protein 1 | 1 | 2019 | 17 | 0.040 |
Why?
|
| ATP-Binding Cassette Transporters | 1 | 2019 | 38 | 0.040 |
Why?
|
| Benzoates | 1 | 2019 | 30 | 0.040 |
Why?
|
| Receptors, G-Protein-Coupled | 1 | 2019 | 87 | 0.040 |
Why?
|
| Methylnitrosourea | 1 | 2018 | 5 | 0.040 |
Why?
|
| Estrogen Receptor alpha | 1 | 2018 | 27 | 0.040 |
Why?
|
| Cohort Studies | 1 | 2020 | 897 | 0.040 |
Why?
|
| Stromal Cells | 1 | 2018 | 62 | 0.030 |
Why?
|
| Organic Cation Transporter 2 | 1 | 2017 | 2 | 0.030 |
Why?
|
| Cell Line | 1 | 2019 | 700 | 0.030 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 1 | 2019 | 285 | 0.030 |
Why?
|
| Enzyme Activation | 1 | 2017 | 267 | 0.030 |
Why?
|
| Inflammation | 1 | 2021 | 667 | 0.030 |
Why?
|
| Hypoglycemic Agents | 1 | 2017 | 110 | 0.030 |
Why?
|
| Head and Neck Neoplasms | 1 | 2017 | 93 | 0.030 |
Why?
|
| Cell Survival | 1 | 2017 | 419 | 0.030 |
Why?
|
| Mice, Mutant Strains | 1 | 2014 | 58 | 0.030 |
Why?
|
| Catalysis | 1 | 2014 | 133 | 0.030 |
Why?
|
| Enzyme Assays | 1 | 2012 | 6 | 0.020 |
Why?
|
| Palmitic Acid | 1 | 2012 | 11 | 0.020 |
Why?
|
| Carbon Isotopes | 1 | 2012 | 43 | 0.020 |
Why?
|
| NADP | 1 | 2012 | 39 | 0.020 |
Why?
|
| Glycolysis | 1 | 2012 | 96 | 0.020 |
Why?
|
| Substrate Specificity | 1 | 2012 | 151 | 0.020 |
Why?
|
| Regression Analysis | 1 | 2012 | 211 | 0.020 |
Why?
|
| Caseins | 1 | 2011 | 2 | 0.020 |
Why?
|
| Caspase 3 | 1 | 2011 | 58 | 0.020 |
Why?
|
| Oxidation-Reduction | 1 | 2012 | 380 | 0.020 |
Why?
|
| Microarray Analysis | 1 | 2011 | 65 | 0.020 |
Why?
|
| Polymerase Chain Reaction | 1 | 2011 | 270 | 0.020 |
Why?
|
| Cytoplasm | 1 | 2010 | 57 | 0.020 |
Why?
|
| Photons | 1 | 2010 | 27 | 0.020 |
Why?
|
| Cell Nucleus | 1 | 2010 | 138 | 0.020 |
Why?
|
| Microscopy, Fluorescence | 1 | 2010 | 163 | 0.020 |
Why?
|
| Fibroblasts | 1 | 2010 | 160 | 0.020 |
Why?
|
| Immunoglobulin J Recombination Signal Sequence-Binding Protein | 1 | 2009 | 6 | 0.020 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2009 | 328 | 0.020 |
Why?
|
| Neoplasm Invasiveness | 1 | 2009 | 190 | 0.020 |
Why?
|
| Blotting, Western | 1 | 2009 | 515 | 0.020 |
Why?
|
| Snail Family Transcription Factors | 1 | 2007 | 10 | 0.020 |
Why?
|
| Mice, Nude | 1 | 2007 | 332 | 0.020 |
Why?
|
| Neoplasm Proteins | 1 | 2007 | 123 | 0.020 |
Why?
|
| Osteopontin | 1 | 2005 | 10 | 0.010 |
Why?
|
| Lipopolysaccharides | 1 | 2005 | 157 | 0.010 |
Why?
|
| Rats, Sprague-Dawley | 1 | 2005 | 554 | 0.010 |
Why?
|